{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:53:51Z","timestamp":1793314431648,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013669","name":"Ionis Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejim.2025.106648","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T20:25:20Z","timestamp":1766521520000},"page":"106648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Prevention and treatment of hypertriglyceridemia-mediated acute pancreatitis: A narrative review"],"prefix":"10.1016","volume":"145","author":[{"given":"Savitha","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handrean","family":"Soran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asia","family":"Sikora Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica R.","family":"McClain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Eckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5599-0633","authenticated-orcid":false,"given":"Robert S.","family":"Rosenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.ejim.2025.106648_bib0001","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.106648_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2025.04.195","article-title":"Hypertriglyceridemia and its relationship with all-cause mortality and pancreatitis: results from a large retrospective clinical registry","author":"Vlacho","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0003","first-page":"106","article-title":"Acute pancreatitis patient registry to examine novel therapies in clinical experience (APPRENTICE): an international, multicenter consortium for the study of acute pancreatitis","volume":"30","author":"Papachristou","year":"2017","journal-title":"Ann Gastroenterol"},{"issue":"4","key":"10.1016\/j.ejim.2025.106648_bib0004","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.pan.2016.02.011","article-title":"Systematic review of hypertriglyceridemia-induced acute pancreatitis: a more virulent etiology?","volume":"16","author":"Carr","year":"2016","journal-title":"Pancreatology"},{"issue":"4","key":"10.1016\/j.ejim.2025.106648_bib0005","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/MPA.0000000000001275","article-title":"Trends and outcomes of hospitalizations related to acute pancreatitis: epidemiology from 2001 to 2014 in the United States","volume":"48","author":"Gapp","year":"2019","journal-title":"Pancreas"},{"issue":"21","key":"10.1016\/j.ejim.2025.106648_bib0006","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025983","article-title":"Factors associated with the severity of hypertriglyceridemia induced acute pancreatitis","volume":"100","author":"Thong","year":"2021","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.ejim.2025.106648_bib0007","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.hpb.2019.01.015","article-title":"Hypertriglyceridaemia-associated acute pancreatitis: diagnosis and impact on severity","volume":"21","author":"Zhang","year":"2019","journal-title":"HPB (Oxford)"},{"issue":"8","key":"10.1016\/j.ejim.2025.106648_bib0008","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.pan.2023.10.009","article-title":"Incident diabetes following acute pancreatitis in a multicenter prospective observational cohort","volume":"23","author":"Bejjani","year":"2023","journal-title":"Pancreatology"},{"issue":"5","key":"10.1016\/j.ejim.2025.106648_bib0009","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/gutjnl-2013-305062","article-title":"Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis","volume":"63","author":"Das","year":"2014","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.ejim.2025.106648_bib0010","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jacl.2016.02.019","article-title":"Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system","volume":"10","author":"Rashid","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"10","key":"10.1016\/j.ejim.2025.106648_bib0011","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/ajg.2015.261","article-title":"Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis","volume":"110","author":"Nawaz","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ejim.2025.106648_bib0012","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2013current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ejim.2025.106648_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2025.08.017","article-title":"Health outcomes and survival among patients with severe hypertriglyceridemia after acute pancreatitis","author":"Broder","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"5","key":"10.1016\/j.ejim.2025.106648_bib0014","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1159\/000512682","article-title":"Association of serum triglyceride levels with severity in acute pancreatitis: results from an international, multicenter cohort study","volume":"102","author":"Pothoulakis","year":"2021","journal-title":"Digestion"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/eurheartj\/ehz785","article-title":"Clinical review on triglycerides","volume":"41","author":"Laufs","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr Physiol"},{"issue":"47","key":"10.1016\/j.ejim.2025.106648_bib0017","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ejim.2025.106648_bib0018","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/metabo13050621","article-title":"Severe hypertriglyceridaemia and chylomicronaemia syndrome-causes, clinical presentation, and therapeutic options","volume":"13","author":"Bashir","year":"2023","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0019","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12944-021-01488-8","article-title":"The association of triglyceride levels with the incidence of initial and recurrent acute pancreatitis","volume":"20","author":"Sanchez","year":"2021","journal-title":"Lipids Health Dis"},{"issue":"5","key":"10.1016\/j.ejim.2025.106648_bib0021","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMc2306575","article-title":"Volanesorsen to prevent acute pancreatitis in hypertriglyceridemia","volume":"390","author":"Alexander","year":"2024","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.ejim.2025.106648_bib0022","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2400201","article-title":"Olezarsen, acute pancreatitis, and familial chylomicronemia syndrome","volume":"390","author":"Stroes","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.106648_bib0023","article-title":"Plozasiran for managing persistent chylomicronemia and pancreatitis risk","author":"Watts","year":"2024","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ejim.2025.106648_bib0046","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/eurheartj\/ehab890","article-title":"Apolipoprotein C-III inhibition to lower triglycerides: one ring to rule them all?","volume":"43","author":"Hegele","year":"2022","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ejim.2025.106648_bib0053","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and triglyceride levels in familial chylomicronemia syndrome","volume":"381","author":"Witztum","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12933-022-01525-5","article-title":"Elevated plasma triglyceride concentration and risk of adverse clinical outcomes in 1.5 million people: a CALIBER linked electronic health record study","volume":"21","author":"Patel","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.ejim.2025.106648_bib0026","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.atherosclerosis.2014.09.029","article-title":"Clinical and economic outcomes in a real-world population of patients with elevated triglyceride levels","volume":"237","author":"Toth","year":"2014","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.ejim.2025.106648_bib0024","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacl.2023.09.002","article-title":"Severe hypertriglyceridemia prevalence at a primary care setting in Catalonia, Spain","volume":"17","author":"Ortega","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ejim.2025.106648_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2025.08.012","article-title":"Prevalence, incidence, and definition of severe hypertriglyceridemia: a comprehensive review and weighted summary","author":"Baass","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"9","key":"10.1016\/j.ejim.2025.106648_bib0027","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline","volume":"97","author":"Berglund","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ejim.2025.106648_bib0028","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jacl.2023.05.099","article-title":"Nutrition interventions for adults with dyslipidemia: a clinical perspective from the National Lipid Association","volume":"17","author":"Kirkpatrick","year":"2023","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0034","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1573403X14666180123165542","article-title":"Hypertriglyceridemia - common causes, prevention and treatment strategies","volume":"14","author":"Rygiel","year":"2018","journal-title":"Curr Cardiol Rev"},{"issue":"20","key":"10.1016\/j.ejim.2025.106648_bib0040","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejim.2025.106648_bib0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacl.2020.01.014","article-title":"Chylomicronemia syndrome: familial or not?","volume":"14","author":"Warden","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"4","key":"10.1016\/j.ejim.2025.106648_bib0086","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/clinem\/dgae613","article-title":"Comparison of patients with familial chylomicronemia syndrome and multifactorial chylomicronemia syndrome","volume":"110","author":"Spagnuolo","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ejim.2025.106648_bib0029","doi-asserted-by":"crossref","first-page":"e1332","DOI":"10.1210\/clinem\/dgaa838","article-title":"10-year comparative follow-up of familial versus multifactorial chylomicronemia syndromes","volume":"106","author":"Belhassen","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2025.106648_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117489","article-title":"Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia","volume":"392","author":"Guay","year":"2024","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.ejim.2025.106648_bib0031","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/ATVBAHA.119.313401","article-title":"Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes","volume":"39","author":"D\u2019Erasmo","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejim.2025.106648_bib0032","doi-asserted-by":"crossref","unstructured":"Davidson M., Stevenson M., Hsieh A., et al. The burden of familial chylomicronemia syndrome: results from the global IN-FOCUS study. J Clin Lipidol 2018;12(4):898\u2013907. e2. 10.1016\/j.jacl.2018.04.009.","DOI":"10.1016\/j.jacl.2018.04.009"},{"issue":"Suppl 5","key":"10.1016\/j.ejim.2025.106648_bib0033","first-page":"e2250","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12884-022-04742-8","article-title":"Acute pancreatitis in pregnancy: a 10-year, multi-center, retrospective study in Beijing","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"10.1016\/j.ejim.2025.106648_bib0036","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/14767058.2014.913132","article-title":"Analyzing and identifying risk factors for acute pancreatitis with different etiologies in pregnancy","volume":"28","author":"Jin","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ejim.2025.106648_bib0037","series-title":"Endotext","article-title":"Medication induced changes in lipid and lipoproteins","author":"Herink","year":"2018"},{"issue":"10","key":"10.1016\/j.ejim.2025.106648_bib0038","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/MPA.0000000000000937","article-title":"Concurrent diabetic ketoacidosis in hypertriglyceridemia-induced pancreatitis: how does it affect the clinical course and severity scores?","volume":"46","author":"Wang","year":"2017","journal-title":"Pancreas"},{"issue":"12","key":"10.1016\/j.ejim.2025.106648_bib0039","doi-asserted-by":"crossref","first-page":"dgaa674","DOI":"10.1210\/clinem\/dgaa674","article-title":"Lipid management in patients with endocrine disorders: an Endocrine Society clinical practice guideline","volume":"105","author":"Newman","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0041","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amjmed.2013.09.018","article-title":"Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia","volume":"127","author":"Christian","year":"2014","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.106648_bib0042","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/oby.23622","article-title":"Real-world weight-loss effectiveness of glucagon-like peptide-1 agonists among patients with type 2 diabetes: a retrospective cohort study","volume":"31","author":"White","year":"2023","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"10.1016\/j.ejim.2025.106648_bib0043","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamainternmed.2013.2720","article-title":"Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study","volume":"173","author":"Singh","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.ejim.2025.106648_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2024.103116","article-title":"Decreased risk of recurrent acute pancreatitis with semaglutide and tirzepatide in people with type 2 diabetes or obesity with a history of acute pancreatitis: a propensity matched global federated TriNetX database-based retrospective cohort study","volume":"18","author":"Nassar","year":"2024","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.ejim.2025.106648_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2025.106648_bib0047","series-title":"TRYNGOLZA\u2122 [package insert]","year":"2024"},{"key":"10.1016\/j.ejim.2025.106648_bib0048","article-title":"Summary of product characteristics","year":"2019","journal-title":"Waylivra\u2122"},{"key":"10.1016\/j.ejim.2025.106648_bib0049","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/DDDT.S224771","article-title":"Volanesorsen in the treatment of familial chylomicronemia syndrome or hypertriglyceridaemia: design, development and place in therapy","volume":"14","author":"Esan","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ejim.2025.106648_bib0050","series-title":"FDA Briefing Document: EMDAC meeting for volanesorsen (Waylivra); U.S. Food and Drug Administration","article-title":"Endocrinologic and Metabolic Drugs Advisory Committee Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.ejim.2025.106648_bib0051","unstructured":"European Medicines Agency. TRYNGOLZA (olezarsen). Updated September 19, 2025.Accessed October 6, 2025, Available at: https:\/\/ec.europa.eu\/health\/documents\/community-register\/html\/h1969.htm."},{"key":"10.1016\/j.ejim.2025.106648_bib0052","series-title":"REDEMPLO(R) [package insert]","year":"2025"},{"key":"10.1016\/j.ejim.2025.106648_bib0054","article-title":"Olezarsen for managing severe hypertriglyceridemia and pancreatitis risk","author":"Marston","year":"2025","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ejim.2025.106648_bib0056","doi-asserted-by":"crossref","first-page":"e2255","DOI":"10.1210\/clinem\/dgae103","article-title":"High hsCRP concentration is associated with acute pancreatitis in multifactorial chylomicronemia syndrome","volume":"109","author":"Guay","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ejim.2025.106648_bib0057","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1016\/j.jacl.2024.02.007","article-title":"Pancreatitis polygenic risk score is associated with acute pancreatitis in multifactorial chylomicronemia syndrome","volume":"18","author":"Guay","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"8","key":"10.1016\/j.ejim.2025.106648_bib0058","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ejim.2014.08.008","article-title":"Current knowledge of hypertriglyceridemic pancreatitis","volume":"25","author":"Valdivielso","year":"2014","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.ejim.2025.106648_bib0059","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/2050640618755002","article-title":"Hypertriglyceridemic pancreatitis: epidemiology, pathophysiology and clinical management","volume":"6","author":"de Pretis","year":"2018","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-15391-0","article-title":"Fatty acid analysis identifies an aberrant circulating triglyceride composition in patients with hypertriglyceridemia-induced acute pancreatitis","volume":"15","author":"Leikin-Frenkel","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2025.106648_bib0061","series-title":"Mechanisms of vascular disease: a reference book for vascular specialists","article-title":"Pathophysiology of reperfusion injury","author":"Cowled","year":"2011"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0062","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s41669-019-0155-y","article-title":"Symptoms and dietary impact in hypertriglyceridemia-associated pancreatitis: development and content validity of two new measures","volume":"4","author":"Burbridge","year":"2020","journal-title":"Pharmacoecon Open"},{"issue":"18","key":"10.1016\/j.ejim.2025.106648_bib0063","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.clinbiochem.2017.07.003","article-title":"Lipase or amylase for the diagnosis of acute pancreatitis?","volume":"50","author":"Ismail","year":"2017","journal-title":"Clin Biochem"},{"issue":"4","key":"10.1016\/j.ejim.2025.106648_bib0064","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1053\/j.gastro.2018.01.032","article-title":"American Gastroenterological Association Institute Clinical Guidelines Committee. American Gastroenterological Association Institute guideline on initial management of acute pancreatitis","volume":"154","author":"Crockett","year":"2018","journal-title":"Gastroenterology"},{"issue":"4 Suppl 2","key":"10.1016\/j.ejim.2025.106648_bib0065","first-page":"e1","article-title":"IAP\/APA evidence-based guidelines for the management of acute pancreatitis","volume":"13","year":"2013","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0066","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","article-title":"Classification of acute pancreatitis\u20132012: revision of the Atlanta classification and definitions by international consensus","volume":"62","author":"Banks","year":"2013","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.ejim.2025.106648_bib0067","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.mcg.0000436438.60145.5a","article-title":"Issues in hypertriglyceridemic pancreatitis: an update","volume":"48","author":"Scherer","year":"2014","journal-title":"J Clin Gastroenterol"},{"issue":"12","key":"10.1016\/j.ejim.2025.106648_bib0068","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s40265-022-01766-4","article-title":"Acute pancreatitis: diagnosis and treatment","volume":"82","author":"Szatmary","year":"2022","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ejim.2025.106648_bib0069","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pan.2021.02.005","article-title":"Hypertriglyceridemia is often under recognized as an aetiologic risk factor for acute pancreatitis: a population-based cohort study","volume":"21","author":"Olesen","year":"2021","journal-title":"Pancreatology"},{"issue":"6","key":"10.1016\/j.ejim.2025.106648_bib0089","doi-asserted-by":"crossref","first-page":"e8926","DOI":"10.1002\/ccr3.8926","article-title":"Eruptive xanthoma as a warning sign of uncontrolled hypertriglyceridemia presenting with acute pancreatitis and uncontrolled type II diabetes mellitus: a case report","volume":"12","author":"Shrestha","year":"2024","journal-title":"Clin Case Rep"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12886-022-02515-7","article-title":"Alterations in ocular microcirculation and oxygen metabolism in patients with lipemia retinalis","volume":"22","author":"Alsarhani","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ejim.2025.106648_bib0070","article-title":"Normal-fat versus fat-restricted diets in patients with acute pancreatitis: a randomized controlled study (NouRish-AP study)","author":"Kittisuphat","year":"2025","journal-title":"Pancreatology"},{"issue":"9","key":"10.1016\/j.ejim.2025.106648_bib0071","doi-asserted-by":"crossref","first-page":"626","DOI":"10.7326\/M19-0203","article-title":"The chylomicronemia syndrome is most often multifactorial: a narrative review of causes and treatment","volume":"170","author":"Chait","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2025.106648_bib0084","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2018.06.814","article-title":"Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an \"FCS score\"","volume":"275","author":"Moulin","year":"2018","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ejim.2025.106648_bib0075","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jca.21922","article-title":"Effect of TPE vs medical management on patient outcomes in the setting of hypertriglyceridemia-induced acute pancreatitis with severely elevated triglycerides","volume":"36","author":"Webb","year":"2021","journal-title":"J Clin Apher"},{"issue":"2","key":"10.1016\/j.ejim.2025.106648_bib0076","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"issue":"1","key":"10.1016\/j.ejim.2025.106648_bib0073","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacl.2024.10.001","article-title":"Hypertriglyceridemia-induced acute pancreatitis in pregnancy associated with CREB3L3 mutation","volume":"19","author":"Gurevitz","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ejim.2025.106648_bib0072","series-title":"UpToDate","article-title":"Hypertriglyceridemia-induced acute pancreatitis","author":"Gelrud","year":"2025"},{"issue":"5","key":"10.1016\/j.ejim.2025.106648_bib0074","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2337\/dc11-1925","article-title":"Effect of diabetes on severity and hospital mortality in patients with acute pancreatitis: a national population-based study","volume":"35","author":"Shen","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2025.106648_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00028-2","article-title":"Futility of plasmapheresis, insulin in normoglycaemic individuals, or heparin in the treatment of hypertriglyceridaemia-induced acute pancreatitis","author":"Syed-Abdul","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.ejim.2025.106648_bib0078","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1172\/JCI110547","article-title":"Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique","volume":"69","author":"Sadur","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2025.106648_bib0079","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4721357","article-title":"Management of hypertriglyceridemia induced acute pancreatitis","volume":"2018","author":"Garg","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ejim.2025.106648_bib0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejim.2023.06.006","article-title":"Recurrence rates and risk factors for recurrence after first episode of acute pancreatitis: a systematic review and meta-analysis","volume":"116","author":"Li","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2025.106648_bib0081","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejim.2024.03.022","article-title":"Recurrence of hypertriglyceridemia-associated acute pancreatitis: a multicenter, prospective cohort study","volume":"125","author":"Ding","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.ejim.2025.106648_bib0082","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1053\/j.gastro.2015.07.066","article-title":"Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis","volume":"149","author":"Sankaran","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2025.106648_bib0083","article-title":"A qualitative study to explore the patient experience of hypertriglyceridemia-related acute pancreatitis","author":"Sikora Kessler","year":"2025","journal-title":"J Clin Lipidol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525005254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525005254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:28:52Z","timestamp":1785205732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525005254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":88,"alternative-id":["S0953620525005254"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106648","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention and treatment of hypertriglyceridemia-mediated acute pancreatitis: A narrative review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106732","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106648"}}